U.S. stock futures are sinking Friday as investors awaited an influx of data on U.S. GDP, manufacturing and consumer sentiment.
02/27/15 - 08:53 AM EST
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
02/27/15 - 06:00 AM EST
Medical device manufacturers Cyberonics and Sorin will join forces and move their headquarters to the U.K. in a deal propelled by the search for lower corporate taxes.
02/26/15 - 11:54 AM EST
U.S. stock futures are bouncing upward on Thursday, as investors await a flood of data on consumer prices, jobless claims and housing.
02/26/15 - 08:49 AM EST
To buy PTC Therapeutics today would cost roughly $3 billion, a significant pile of cash to risk on an investment that could blow up at the end of the year.
02/25/15 - 11:47 AM EST
U.S. stock futures are mixed as investors await Federal Reserve Chair Janet Yellen's continued testimony before Congress, and as the Nasdaq reaches toward 5,000.
02/25/15 - 08:17 AM EST
It is no pipe dream that the stock could trade to $240
02/24/15 - 11:39 AM EST
U.S. stock futures aren't moving much as investors await Federal Reserve Chair Janet Yellen's Congressional testimony.
02/24/15 - 06:42 AM EST
Investors are cheering for Valeant Pharmaceutical's planned $14.5 billion acquisition of Salix Pharmaceuticals, but Salix shareholders were hoping for more.
02/23/15 - 11:51 AM EST
The pharma giant is making an upfront payment of $800 million and committing to up to $450 million more in milestone payments.
02/23/15 - 11:14 AM EST
U.S. stock futures look negative, although stocks ended last week at a record high.
02/23/15 - 07:20 AM EST
Canada's Valeant Pharma agreed to buy Salix Pharma in cash deal valued at about $14.5 billion, the companies said Sunday.
02/22/15 - 08:37 PM EST